PRE

Prenetics Global Ltd

PRE, USA

Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

https://www.prenetics.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
PRE
stock
PRE

Why Rocket Lab stock reversed from a massive pre-market rally to 8% decline TradingView — Track All Markets

Read more →
PRE
stock
PRE

MIST stock soars pre-market after FDA approves first commercial product – retail remains bullish, dismisses 'sell the news' concerns MSN

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$31

Analyst Picks

Strong Buy

1

Buy

0

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

1.28

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-4.59 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-3.77 %

Low ≤ 2%

High ≥ 10%

Debt to Equity

-

Very High

0.22

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 9.80% of the total shares of Prenetics Global Ltd

1.

Prudential Corp PLC

(3.2834%)

since

2025/06/30

2.

Aspex Management (HK) Ltd

(2.6558%)

since

2025/06/30

3.

Nomura Holdings Inc

(2.4691%)

since

2025/06/30

4.

abrdn World Healthcare

(0.7045%)

since

2025/07/31

5.

BlackRock Inc

(0.1904%)

since

2025/06/30

6.

iShares Micro-Cap ETF

(0.1812%)

since

2025/08/31

7.

MY PURPOSEFUL WEALTH CORP

(0.1334%)

since

2025/06/30

8.

Morgan Stanley - Brokerage Accounts

(0.0685%)

since

2025/06/30

9.

UBS Group AG

(0.0524%)

since

2025/06/30

10.

Fidelity Nasdaq Composite Index

(0.0483%)

since

2025/07/31

11.

1290 VT Micro Cap K

(0.0159%)

since

2025/07/31

12.

Bank of America Corp

(0.0009%)

since

2025/06/30

13.

Wolverine Asset Management LLC

(0%)

since

2025/06/30

14.

SBI Securities Co Ltd

(0%)

since

2025/06/30

15.

Quinn Opportunity Partners LLC

(0%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.53

EPS Estimate

-0.55

EPS Difference

0.02

Surprise Percent

3.6364%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.8)
GARP
Fair GARP(4.5)
Growth
Weak Growth Prospect(3)
Momentum
No Momentum(2)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(2.5)
Value
Fair Value(4.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.